WANY
OLMA icon

Wealthspire Advisors (New York)’s Olema Pharmaceuticals OLMA Stock Holding History

Wealthspire Advisors (New York)’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$152K Hold
10,172
– – ﹤0.01% 883
2025
Q4 		$254K Buy
+10,172
New +$181K ﹤0.01% 873

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Wealthspire Advisors (New York)'s OLMA Position: Q1 2026 in Review

Wealthspire Advisors (New York) held its Olema Pharmaceuticals (OLMA) position steady in Q1 2026 at 10,172 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #883.

Wealthspire Advisors (New York) first reported a position in OLMA in Q4 2025 and has held it in 2 quarters since. The position peaked at $254K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Wealthspire Advisors (New York) held 10,172 shares of Olema Pharmaceuticals worth $152K as of Q1 2026.
  • Wealthspire Advisors (New York) left its Olema Pharmaceuticals share count unchanged in Q1 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q1 2026, its #883 holding.
  • Wealthspire Advisors (New York) first reported a position in Olema Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Wealthspire Advisors (New York)'s Olema Pharmaceuticals position peaked at $254K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.